- ►annals.org [PDF] C Heidemann, Q Sun, RM van Dam, JB Meigs, … - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Adiponectin and resistin are recently discovered adi- pokines that
may provide a molecular link between adiposity and type 2 diabetes. ...
Objective: To evaluate whether total and high-molecular-weight adiponectin ... Cited by 16 - Related articles - All 5 versions
MB Schulze, CG Solomon, N Rifai, RM Cohen … - Diabetic Medicine, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 6 - Related articles - BL Direct - All 4 versions
- ►endojournals.org MF Hivert, LM Sullivan, CS Fox, DM Nathan, … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Objective: We tested the hypothesis that adipokines are associated with insulin
resistance in a community-based cohort and that associations are maintained in
people with and without the metabolic syndrome (high vs. low risk of diabetes). Cited by 20 - Related articles - All 5 versions
RC Kaplan, GYF Ho, XN Xue, S Rajpathak, M … - Cancer Epidemiology Biomarkers & Prevention, 2007 - AACR Obesity has long been recognized as a risk factor for early mortality, cancer,
and other common chronic diseases including coronary heart disease, stroke, and
diabetes (1, 2). Recent data suggest that adipose tissue is not merely a ... Cited by 8 - Related articles - BL Direct - All 4 versions
AB Goldfine - New England Journal of Medicine, 2008 - content.nejm.org Clinical treatment goals for patients with type 2 diabetes include alleviating
acute symptoms of hyperglycemia and forestalling diabetes-related complications.
Drugs that are approved by the FDA for treating diabetes are indicated for ... Cited by 10 - Related articles - All 3 versions
S Havas - Archives of Internal Medicine, 2009 - Am Med Assoc The decision by the National Institutes of Health to discontinue the
glucose-lowering portion of the Action to Control Cardiovascular Risk in
Diabetes (ACCORD) Trial unexpectedly after 3.5 years because of an ... Cited by 10 - Related articles - All 5 versions
K Jalovaara, M Santaniemi, M Timonen, J … - Metabolism, 2008 - Elsevier Low levels of adiponectin are associated with obesity and type 2 diabetes
mellitus (DM2). However, only few studies on this topic have used the most
recent World Health Organization 1999 criteria, which include a definition ... Cited by 10 - Related articles - All 20 versions
- ►ajcn.org [PDF] A Due, TM Larsen, H Mu, K Hermansen, S … - American Journal of Clinical Nutrition, 2008 - Am Soc Nutrition Comparison of 3 ad libitum diets for weight-loss maintenance, risk ... Anette
Due, Thomas M Larsen, Huiling Mu, Kjeld Hermansen, Steen Stender, and Arne
Astrup ... ABSTRACT Background: The optimal dietary content and type of ... Cited by 12 - Related articles - All 6 versions
JA Nettleton, LM Steffen, H Ni, K Liu, DR … - Diabetes Care, 2008 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—White, black, Hispanic, and Chinese adults, aged
45–84 years and free of cardiovascular disease and diabetes, completed food
frequency questionnaires at baseline (2000–2002). Incident type 2 ... Cited by 11 - Related articles - All 7 versions
AM Kanaya, W Fyr… - Archives of Internal Medicine, 2006 - Am Med Assoc Methods We analyzed the relationships among adiposity, adipocytokines, glycemia,
and incident diabetes mellitus in 2356 white and black adults aged 70 to 79
years in the Health, Aging, and Body Composition Study who did not have ... Cited by 39 - Related articles - All 4 versions
